Topics
Glioma | Outcomes | Response assessment
Home > Publications > Topics > Glioma > Outcomes > Response assessment
Shiroishi MS, Erickson BJ, Hu LS,
Barboriak DP, Becerra L, Bell LC, Boss MA, Boxerman
JL, Cen S, Cimino L, Fan Z, Keenan KE, Kirsch JE, Ameli N, Nazemi
S, Quarles CC, Rosen MA,
Rodriguez L, Schmainda KM, Zahlmann G, Zhou Y, Obuchowski
N, Wu O; RSNA QIBA Dynamic
Susceptibility Contrast MRI Biomarker Committee.
The
QIBA
Profile for Dynamic Susceptibility Contrast MRI Quantitative
Imaging Biomarkers
for Assessing Gliomas.
Radiology.
2024 Dec 10;313(3):e232555.
doi:
10.1148/radiol.232555. PMID:
39656118. Review˰ ˍ
van den Bent MJ, Cloughesy TF, Ellingson BM, Allen JE, Blackman
SC, Kieran MW, Tonn JC, Karschnia P, Wijnenga M, Pallud J, Young
RJ, Huang RY, Mellinghoff IK, de Groot J, van der Hoorn A, Youssef
G, Hervey-Jumper SL, Vogelbaum MA, Chang SM, Wen PY.
The
Use of Minor Response, Volumetric Assessment and Growth Rate
Kinetics as Endpoints in Grade 1-3 Glioma Clinical Trials: a RANO
perspective.
Neuro
Oncol. 2025 Jul 19:noaf173. doi:
10.1093/neuonc/noaf173. PMID:
40692474. Perspective˰
ˍ